Xbiotech Inc.
SEC CIK 1626878 · xbit · last insider filing 2025-11-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rademaker Craig Evan | Director | filed 2025 - 2025 |
| Troy Tevi David | Director | filed 2025 - 2025 |
| Kuendig Thomas Martin | Director | filed 2025 - 2025 |
| Soffer David Spencer | Director | filed 2025 - 2025 |
| Simard John | Director · President, CEO & Chairman | filed 2015 - 2025 |
| Mckenzie W Thorpe | Director | filed 2015 - 2024 |
| Waldin Jan-Paul | Director | filed 2018 - 2024 |
| Macadam Donald H. | Director | filed 2018 - 2024 |
| Libby Peter | Director | filed 2019 - 2024 |
| Vasella Daniel | Director | filed 2015 - 2017 |
| Bonanni Fabrizio | Director | filed 2015 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| HU Angela | Principle Financial Officer | filed 2023 - 2023 |
| Shivaswamy Sushma | VP of R&D | filed 2015 - 2023 |
| HAN Queena | VP of Fin & HR, Secretary | filed 2015 - 2021 |
| Guzman Benjamin | Sr.VP Corp. Strategy & Finance | filed 2017 - 2017 |
| Stecher Michael | Medical Director | filed 2015 - 2017 |
| Benson Trey | VP of Commercial Development | filed 2016 - 2016 |
| Choudhury Kalidip | VP of Business Development | filed 2016 - 2016 |
| Mccollough Dawn | VP Clinical Operations | filed 2016 - 2016 |
| Whitehurst James Scott | Chief Financial Officer | filed 2016 - 2016 |
| Thornburg Kelly | SVP of Operations | filed 2015 - 2015 |
| Gonzalez Norma I | Vice President, Quality | filed 2015 - 2015 |
| Combs David J | Vice President, Manufacturing | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.